In response to the financial market crisis of 2008 and 2009, the G-20 countries decided to thoroughly revamp the market infrastructure for over-the-counter derivative transactions.

Alongside the USA, the EU is playing a leading role in the drafting of new regulatory requirements and has already presented numerous complex regulatory regimes dealing with the various aspects of trade with OTC derivatives: from the conclusion and central clearing of OTC derivatives contracts (EMIR) through trade (MiFIR) and capital requirements (CRD IV) to settlement (RCSD). The entire regulatory package is to be completed by the end of this year.

The newly created lists of obligations, and those yet to be established, will directly affect not only professional market players such as banks, securities companies and UCITs, but also industrial enterprises and other non-financial counterparties. Our early bird seminar will give you a condensed, pragmatic overview of the new market infrastructure for OTC derivatives and the framework conditions that are relevant for your company. We will brief you on the state of legislation as well as on current developments and provide an outlook on the main milestones and to-dos that are to be expected in the coming months and years.

You will find the presentation here.